The site is currently undergoing maintenance and you will not be able to register for events and education courses or for membership at this time. If you have any further queries, please contact or call 0207 842 0900 in office hours.


COVID-19 resources

Read all of BSR's resources on rheumatology and COVID-19.


COVID-19 guidance

Find out more

New results: COVID-19 impact on rare autoimmune rheumatic diseases

Higher risks for patients, says researcher Megan Rutter in this updated research
Find out more

Research Funding Call winner: increased risk of COVID-19 and death for those with rare autoimmune rheumatic diseases

Congratulations to Dr Megan Rutter, who's just released an important piece of COVID-19 research
Find out more

COVID-19: research into experiences of lupus patients

Under 30% of patients with lupus and other systemic autoimmune rheumatic diseases felt medically supported during the first wave of the pandemic
Find out more

Supporting clinicians: implementing COVID-19 Green Book recommendations

Pressing to ensure clinically extremely vulnerable patients are offered vaccination before planned immunosuppression
Find out more

Easy access: all of our COVID-19 resources

Need some resources for COVID-19? We've compiled everything we have into one handy news story
Find out more

Arthritis drugs could help save lives of COVID-19 patients

Our perspective on the recent COVID-19 news around tocilizumab and sarilumab
Find out more

COVID-19: managing rheumatology services with reduced capacity

Find out how services can be managed alongside key constraints such as staffing levels
Find out more

COVID-19: risk assessment tools and patient vulnerability

Prof Karen Walker-Bone on recently developed COVID-19 risk assessment tools
Find out more

New guidance: COVID-19 vaccinations

We've developed some guidance for rheumatology professionals, based on advice from the Joint Committee of Vaccination and Immunisation
Find out more

If you have any queries related to COVID-19 and rheumatology, please email our Policy team, who'll be happy to help.

Get in touch